About: http://data.cimple.eu/news-article/5c9dec883cd3b21fda6fd120cbd4588856aef631f0090edfe5e7bcf1

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/5c9dec883cd3b21fda6fd120cbd4588856aef631f0090edfe5e7bcf1 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Norwegian health officials reported three more cases of blood clots or brain haemorrhages in younger people who received the AstraZeneca Covid-19 jab, but said they could not yet say they were vaccine-related. The Norwegian Medicines Agency said similar incidents had been reported in other European countries. While there was no proof of a link to the vaccine, anyone under 50 who felt unwell and developed large blue patches after vaccination should seek medical attention. The World Health Organization said no causal link had been established between the vaccine and blood clotting after Denmark, Norway and Iceland on Thursday temporarily suspended the use of the vaccine over concerns about patients developing post-jab blood clots. A number of other countries have also suspended use of vaccines from one batch. The manufacturer and Europe's medicines watchdog have meanwhile insisted that the vaccine is safe. Denmark was first to announce its suspension, although it stressed that the move was precautionary, and that "it has not been determined, at the time being, that there is a link between the vaccine and the blood clots". On Saturday, the Norwegian Medicines Agency said it had "received several adverse event reports about younger vaccinated people with bleeding under the skin (tiny dots and /or larger blue patches) after coronavirus vaccination. "This is serious and can be a sign of reduced blood platelet counts," it said. "Today, we received three more reports of severe cases of blood clots or brain haemorrhages in younger people who have received the AstraZeneca vaccine. These are now receiving hospital treatment," it added Geir Bukholm, director of Infection Control and Environmental Health at the Norwegian Institute of Public Health, said that following the decision to suspend the jab, it was now "the Norwegian Medicines Agency's role to follow up on these suspected side effects and take the necessary measures". AstraZeneca, an Anglo-Swedish company which developed the vaccine with Oxford University, has defended the safety of its product. "The safety of the vaccine has been extensively studied in phase III clinical trials and peer-reviewed data confirms the vaccine has been generally well tolerated," a spokesman for the group told AFP. hdy/phy/har/jj
schema:headline	Norway probes blood clot cases after jab suspension
schema:mentions	Unwell Bleeding Peer review Thrombosis Agence France-Presse Clinical trial Iceland Jab University of Oxford Denmark Norway World Health Organization AstraZeneca European Union Vaccine Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Norwegian Medicines Agency Adverse effect Platelet Geir Hallgrímsson PHY (chip)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-13 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	85 (xsd:integer)
http://data.cimple...tology#hasEmotion	fear
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software